ATRC (AtriCure) Tariff Resilience Score: 6/10 (As of Jun. 29, 2026)


ATRC AtriCure Inc ATRC
78 GF Score
Price $30.12
GF Value $39.75
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is AtriCure Tariff Resilience Score?

AtriCure ATRC +7.29% 78 Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus rates ATRC with a GF Score™ of 78/100 and a GF Value™ of $39.75 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 839 Medical Devices & Instruments companies, AtriCure ranks better than 90.94% on this metric.

AtriCure has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

AtriCure has AtriCure's medical device industry faces moderate tariff risks, especially for components sourced internationally. The company has some pricing power and can explore alternative suppliers, but its global sales expose it to potential tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes AtriCure might have Average Resilient.


AtriCure  (NAS:ATRC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

AtriCure Tariff Resilience Score Related Terms


ATRC vs KMTS, STAA, BLFS: Tariff Resilience Score Comparison

For the Medical Instruments & Supplies subindustry, AtriCure's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtriCure Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where AtriCure's Tariff Resilience Score falls into.


ATRC
78GF Score
AtriCure Inc ATRC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
AtriCure (ATRC) has a Tariff Resilience Score of 6 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, AtriCure ranks #76 out of 839 companies in the Medical Devices & Instruments industry, placing it in the top 9.1%.
Is AtriCure's Tariff Resilience Score too high?
AtriCure's current Tariff Resilience Score is 6. Based on the distribution chart, AtriCure ranks #76 out of 839 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AtriCure has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AtriCure's Tariff Resilience Score compare to KMTS and STAA?
According to the Medical Devices & Instruments industry distribution chart, AtriCure ranks #76 out of 839 companies for Tariff Resilience Score. This places AtriCure in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. AtriCure's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AtriCure stock overvalued right now?
Based on GuruFocus' analysis, AtriCure (ATRC) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.75, compared to a current price of $30.12 — trading 24.2% below its estimated fair value. The current Tariff Resilience Score is 6. AtriCure's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For AtriCure (ATRC), the current Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be undervalued. The current stock price of $30.12 is trading 24.2% below its estimated GF Value™ of $39.75. GuruFocus considers AtriCure to be Modestly Undervalued.

Key valuation signals for ATRC:

  • Tariff Resilience Score: 6
  • GF Value™: $39.75 vs. price of $30.12 (24.2% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AtriCure Business Description

Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
78GF Score

Get the complete analysis for ATRC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.12
Price
$39.75
GF Value